It was intraurethrally administered by mean of sterile catheter during Chemical Biology Phase I embryonic augmentation protocol of the Myrmidon Program.
Attributes | Values |
---|---|
rdfs:label |
|
rdfs:comment |
|
dbkwik:halo-fanon/...iPageUsesTemplate | |
dbkwik:halofanon/p...iPageUsesTemplate | |
abstract |
|